Cargando…
Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome
Cardiorenal syndrome (CRS) results from complex interaction between heart and kidneys, inducing simultaneous acute or chronic dysfunction of these organs. Although its incidence rate is increasing with higher mortality in patients, effective clinical treatment drugs are currently not available. The...
Autores principales: | Wang, Shuangcui, Wang, Yuli, Deng, Yun, Zhang, Jiaqi, Jiang, Xijuan, Yu, Jianchun, Gan, Jiali, Zeng, Wenyun, Guo, Maojuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196136/ https://www.ncbi.nlm.nih.gov/pubmed/37214467 http://dx.doi.org/10.3389/fphar.2023.1167260 |
Ejemplares similares
-
Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
por: Mustafa, Nor Hidayah, et al.
Publicado: (2022) -
NLRP3 inflammasome as a novel therapeutic target for heart failure
por: Wang, Shuangcui, et al.
Publicado: (2021) -
Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021) -
Sacubitril/Valsartan Reduces Fibrosis and Alleviates High-Salt Diet-Induced HFpEF in Rats
por: Zhang, Wenchao, et al.
Publicado: (2021) -
Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis
por: Xiang, Qian, et al.
Publicado: (2022)